Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis

  • Alice B. Gottlieb
  • , Sewon Kang
  • , Kenneth G. Linden
  • , Mark Lebwohl
  • , Alan Menter
  • , Ahsan A. Abdulghani
  • , Michael Goldfarb
  • , Nicole Chieffo
  • , Mark C. Totoritis

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Medicine and Dentistry